Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. - Analysis by DXA-based 3D-modeling (3D-SHAPER Software) -TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure).

IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Junichi Takada, Nobukazu Okimoto, Manabu Tsukamoto, Tomohiro Akatsuka, Tsuneo Takebayashi, Kousuke Iba, Satoshi Ikeda
{"title":"Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. - Analysis by DXA-based 3D-modeling (3D-SHAPER Software) -TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure).","authors":"Junichi Takada, Nobukazu Okimoto, Manabu Tsukamoto, Tomohiro Akatsuka, Tsuneo Takebayashi, Kousuke Iba, Satoshi Ikeda","doi":"10.1007/s11657-024-01415-1","DOIUrl":null,"url":null,"abstract":"<p><p>Trends toward more favorable improvement of the cortical bone parameters by once-weekly (56.5 μg once a week) and twice-weekly teriparatide (28.2 μg twice a week), and that of the trabecular bone parameters by once-daily (1/D) teriparatide (20 μg/day once a day) were shown.</p><p><strong>Purpose: </strong>To examine the effects of differences in the amount of teriparatide (TPTD) per administration and its dosing frequency on the bone structure in the proximal femur by dual-energy X-ray absorptiometry (DXA)-based 3D-modeling (3D-SHAPER software).</p><p><strong>Methods: </strong>This was a multicenter retrospective study. Patients aged 50 years or older with primary osteoporosis who continuously received once-/twice-weekly (1・2/W, n = 60) or 1/D TPTD (n = 14) administration for at least one year were included in the study. Measurement regions included the femoral neck (FN), trochanter (TR), femoral shaft (FS), and total proximal hip (TH). Concurrently, the bone mineral density (BMD) and Trabecular Bone Score (TBS) were measured.</p><p><strong>Results: </strong>The cross-sectional area, cross-sectional moment of inertia, and section modulus in the FS were significantly improved in the 1・2/W TPTD group, as compared to the 1/D TPTD group. However, significant improvement of the cortical thickness and buckling ratio in the FN was observed in the 1/D TPTD group, as compared to the 1・2/W TPTD group. Trabecular BMD values in the FS and TH were significantly increased in the 1/D TPTD group, as compared to the 1・2/W TPTD group, while the cortical BMD values in the TR, FS, and TH were significantly increased in the 1・2/W TPTD group, as compared to the 1/D TPTD group.</p><p><strong>Conclusion: </strong>Trends toward more favorable improvement of the cortical bone by 1・2/W TPTD and that of the trabecular bones by 1/D TPTD were observed.</p>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Osteoporosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11657-024-01415-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Trends toward more favorable improvement of the cortical bone parameters by once-weekly (56.5 μg once a week) and twice-weekly teriparatide (28.2 μg twice a week), and that of the trabecular bone parameters by once-daily (1/D) teriparatide (20 μg/day once a day) were shown.

Purpose: To examine the effects of differences in the amount of teriparatide (TPTD) per administration and its dosing frequency on the bone structure in the proximal femur by dual-energy X-ray absorptiometry (DXA)-based 3D-modeling (3D-SHAPER software).

Methods: This was a multicenter retrospective study. Patients aged 50 years or older with primary osteoporosis who continuously received once-/twice-weekly (1・2/W, n = 60) or 1/D TPTD (n = 14) administration for at least one year were included in the study. Measurement regions included the femoral neck (FN), trochanter (TR), femoral shaft (FS), and total proximal hip (TH). Concurrently, the bone mineral density (BMD) and Trabecular Bone Score (TBS) were measured.

Results: The cross-sectional area, cross-sectional moment of inertia, and section modulus in the FS were significantly improved in the 1・2/W TPTD group, as compared to the 1/D TPTD group. However, significant improvement of the cortical thickness and buckling ratio in the FN was observed in the 1/D TPTD group, as compared to the 1・2/W TPTD group. Trabecular BMD values in the FS and TH were significantly increased in the 1/D TPTD group, as compared to the 1・2/W TPTD group, while the cortical BMD values in the TR, FS, and TH were significantly increased in the 1・2/W TPTD group, as compared to the 1/D TPTD group.

Conclusion: Trends toward more favorable improvement of the cortical bone by 1・2/W TPTD and that of the trabecular bones by 1/D TPTD were observed.

Abstract Image

特立帕肽剂量和频率差异对股骨近端骨结构的影响。- 通过基于 DXA 的 3D 建模(3D-SHAPER 软件)进行分析--TRIPLE-BONE 研究(特立帕肽制剂对骨矿物质密度增加和骨结构的影响)。
结果表明,每周一次(每周一次,每次 56.5 μg)和每周两次(每周两次,每次 28.2 μg)服用特立帕肽能更有效地改善骨皮质参数,而每日一次(1/D)服用特立帕肽(每日一次,每次 20 μg)能更有效地改善骨小梁参数。目的:通过基于双能 X 射线吸收仪(DXA)的三维建模(3D-SHAPER 软件),研究特立帕肽(TPTD)每次给药量和给药频率的不同对股骨近端骨结构的影响:这是一项多中心回顾性研究。研究对象包括 50 岁或以上的原发性骨质疏松症患者,这些患者连续接受每周一次/两次(1・2/W,n = 60)或 1/D TPTD(n = 14)治疗至少一年。测量区域包括股骨颈(FN)、股骨转子(TR)、股骨干(FS)和全髋关节近端(TH)。同时还测量了骨矿密度(BMD)和骨小梁评分(TBS):结果:与 1/D TPTD 组相比,1・2/W TPTD 组 FS 的横截面积、横截面惯性矩和横截面模量明显改善。然而,与 1・2/W TPTD 组相比,1/D TPTD 组 FN 的皮质厚度和屈曲比有明显改善。与 1・2/W TPTD 组相比,1/D TPTD 组 FS 和 TH 的骨小梁 BMD 值明显增加,而与 1/D TPTD 组相比,1・2/W TPTD 组 TR、FS 和 TH 的皮质 BMD 值明显增加:结论:1・2/W TPTD 对皮质骨的改善和 1/D TPTD 对小梁骨的改善均呈良好趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Archives of Osteoporosis
Archives of Osteoporosis ENDOCRINOLOGY & METABOLISMORTHOPEDICS -ORTHOPEDICS
CiteScore
5.50
自引率
10.00%
发文量
133
期刊介绍: Archives of Osteoporosis is an international multidisciplinary journal which is a joint initiative of the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA. The journal will highlight the specificities of different regions around the world concerning epidemiology, reference values for bone density and bone metabolism, as well as clinical aspects of osteoporosis and other bone diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信